Literature DB >> 12077094

Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer.

V C Petersen1, K J Baxter, S B Love, N A Shepherd.   

Abstract

BACKGROUND AND AIMS: There is a need for objective easily determined pathological prognostic parameters in Dukes' B colon carcinoma to allow selection of such patients for further treatment as the role of adjuvant chemotherapy for these patients remains unclear. This study was initiated to assess the influence of pathological factors on prognosis in an unselected prospective series of Dukes' B colonic cancer.
METHODS: The Gloucester Colorectal Cancer study, established in 1988, recruited more than 1000 cases. Meticulous pathological assessment of the 268 Dukes' B colonic cancer resections in this series included evaluation of all pathological factors that could influence staging and prognosis. All patients entered a comprehensive follow up system.
RESULTS: Four pathologically determined factors--peritoneal involvement, venous spread (both submucosal and extramural), spread to involve a surgical margin, and perforation through the tumour-were independent prognostic factors in multivariate analysis. Combining these four factors into a simple cumulative scoring system generated clinically useful prognostic groups.
CONCLUSIONS: The cumulative prognostic index allows apportionment of patients with Dukes' B colon cancer into defined prognostic groups, which in turn could allow more objective selection of patients for adjuvant therapy, especially as part of clinical trials.

Entities:  

Mesh:

Year:  2002        PMID: 12077094      PMCID: PMC1773289          DOI: 10.1136/gut.51.1.65

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Adjuvant chemotherapy in Dukes' B and C colorectal cancer has only a minor influence on psychological distress.

Authors:  J Norum
Journal:  Support Care Cancer       Date:  1997-07       Impact factor: 3.603

2.  Colorectal cancer reporting: are we failing the patient?

Authors:  N A Shepherd; P Quirke
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

3.  The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation.

Authors:  N A Shepherd; K J Baxter; S B Love
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

4.  Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis.

Authors:  S Dubé; F Heyen; M Jenicek
Journal:  Dis Colon Rectum       Date:  1997-01       Impact factor: 4.585

5.  Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients.

Authors:  R C Newland; O F Dent; P H Chapuis; L Bokey
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

6.  Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis.

Authors:  J Norum; B Vonen; J A Olsen; A Revhaug
Journal:  Ann Oncol       Date:  1997-01       Impact factor: 32.976

7.  Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

Authors:  M J O'Connell; J A Mailliard; M J Kahn; J S Macdonald; D G Haller; R J Mayer; H S Wieand
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

8.  Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.

Authors: 
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

9.  Role of circumferential margin involvement in the local recurrence of rectal cancer.

Authors:  I J Adam; M O Mohamdee; I G Martin; N Scott; P J Finan; D Johnston; M F Dixon; P Quirke
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

10.  Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.

Authors:  W Scheithauer; G V Kornek; A Marczell; J Karner; G Salem; R Greiner; D Burger; F Stöger; J Ritschel; E Kovats; H M Vischer; B Schneeweiss; D Depisch
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

View more
  58 in total

1.  A long hard look at Dukes' B.

Authors:  G T Williams
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database.

Authors:  Gregoire Desolneux; Pascal Burtin; Emilie Lermite; Roberto Bergamaschi; Antoine Hamy; Jean Pierre Arnaud
Journal:  Int J Colorectal Dis       Date:  2010-04-20       Impact factor: 2.571

3.  Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.

Authors:  F Al-Mulla; S AlFadhli; A H Al-Hakim; J J Going; M S Bitar
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  Recommendations for the reporting of surgically resected specimens of colorectal carcinoma.

Authors:  Jeremy R Jass; Michael J O'Brien; Robert H Riddell; Dale C Snover
Journal:  Virchows Arch       Date:  2006-11-25       Impact factor: 4.064

5.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

6.  Adjuvant therapy of colon cancer: current status and future developments.

Authors:  Michael A Morse
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  Prognostic analysis and comparison of colon cancer in Han and Hui patients.

Authors:  Mei Zhang; Qu-Chuan Zhao; Yan-Peng Liu; Lei Yang; Hong-Ming Zhu; Jagadish K Chhetri
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Emergency presentation of node-negative colorectal cancer treated with curative surgery is associated with poorer short and longer-term survival.

Authors:  Raymond Oliphant; David Mansouri; Gary A Nicholson; Donald C McMillan; Paul G Horgan; David S Morrison
Journal:  Int J Colorectal Dis       Date:  2014-03-22       Impact factor: 2.571

9.  Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging.

Authors:  Young Taik Oh; Myeong Jin Kim; Joon Seok Lim; Joo Hee Kim; Kang Young Lee; Nam Kyu Kim; Won Ho Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2005 Jan-Mar       Impact factor: 3.500

10.  Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology.

Authors:  Eva J A Morris; Nicola J Maughan; David Forman; Philip Quirke
Journal:  Gut       Date:  2007-05-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.